Diagnosis and Management of Non-Atopic Forms of Dermatitis in Atopic Dermatitis Patients

At AAD 2022 | March 24, 2022 | 2:00-5:30 pm EDT

Boston Convention & Exhibition Center (Boston, MA) | Room 151AB 

This symposium will take place prior to the American Academy of Dermatology 2022 Annual Meeting (AAD) in Boston, MA, USA.

Watch On-Demand Webcasts

PROGRAM GOALS
• Analyze the pathophysiology of non-atopic forms of dermatitis
• Recognize allergic, irritant and protein contact dermatitis in AD patients
• Examine patch testing in AD patients and the impact of flares and systemic medications

This educational symposium presented by the IEC is offered at no cost to attendees.

PROGRAM CO-CHAIRS

Robert Bissonnette, IEC President
Robert Bissonnette, MD FRCPC, is Board certified in dermatology and the president of Innovaderm Research—a contract research organization (CRO) specializing in the design, conduct, and analysis of clinical trials in various areas of dermatology—in Montreal, QC, Canada.

AGENDA

2:00 – 2:10 pm Welcome and Introductions | Robert Bissonnette, IEC President | Montreal, QC, Canada

2:10– 2:40 pm Pathophysiology of non-atopic forms of dermatitis | Emma Guttman, IEC Immediate Past-President | New York, NY, USA

2:40 – 3:10 pm Allergic contact dermatitis in AD patients | Mette Deleuran | Aarhus, Denmark

3:10 – 3:40 pm Irritant contact dermatitis in AD patients | Jonathan Silverberg | Washington, D.C., USA

3:40 – 4:10 pm AD patients with new-onset dermatitis on the face | Eric Simpson | Portland, OR, USA

4:10 – 4:25 pm Break

4:25 – 4:55 pm Patch testing in AD patients: impact of flares and system medications | David Cohen | New York, NY, USA

4:55 – 5:25 pm Panel Discussion and Questions | All Speakers

5:25 – 5:30 pm Closing Comments | Robert Bissonnette | Montreal, QC, Canada

Please note IEC will be following AAD/Boston, MA health and safety protocols in accordance with Boston's "B Together" Policy

COVID-19 VACCINATION STATUS
Based on the recent change to the Boston city ordinance on vaccine requirements, the AAD will no longer require proof of vaccination to attend the AAD Annual Meeting. The AAD will continue following all CDC guidelines, as well as state, local, and facility regulations.

For those traveling internationally, there may be additional requirements in place. Please check with your airline and current U.S. entry guidelines.

MASK MANDATE
Currently, there is a mask mandate in Boston and at the Boston Convention & Exhibition Center. We are following all CDC guidelines related to COVID-19 and particularly CDC guidelines and convention center recommendations for large group events. 

View additional health and safety travel resources: https://www.aad.org/member/meetings-education/am22/housing/travel-safety